Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros










Intervalo de ano de publicação
3.
Rev. esp. med. nucl. imagen mol. (Ed. impr.) ; 36(4): 260-262, jul.-ago. 2017. ilus
Artigo em Espanhol | IBECS | ID: ibc-163745

RESUMO

Se presenta el caso de una niña de 3 años pluripatológica, con una enfermedad genética mitocondrial (encefalomiopatía necrosante subaguda o síndrome de Leigh), insuficiencia renal crónica estadio v por una esclerosis mesangial difusa y alteraciones del desarrollo, que fue diagnosticada de hipertiroidismo autoinmune por enfermedad de Graves-Basedow. A las 6 semanas del inicio terapéutico con neocarbimazol, la paciente presentó un cuadro de agranulocitosis severa que obligó a suspender la medicación con fármacos antitiroideos, motivo por el cual fue tratada de manera eficaz con terapia metabólica con 131I. La relevancia del artículo radica en la infrecuencia de la enfermedad de Graves en niños prepuberales (especialmente menores de 6 años), las complicaciones en el desarrollo derivadas de un posible diagnóstico tardío, la aparición de agranulocitosis como efecto adverso potencialmente grave tras el uso de antitiroideos y los pocos casos reportados de terapia ablativa con 131I a esta edad, que otorgan singularidad al caso (AU)


The case is presented of a 3 year-old girl with mitochondrial disease (subacute necrotizing encephalomyelopathy of Leigh syndrome), v-stage chronic kidney disease of a diffuse mesangial sclerosis, as well as developmental disorders, and diagnosed with hyperthyroidism Graves-Basedow disease. Six weeks after starting the treatment with neo-carbimazole, the patient reported a serious case of agranulocytosis. This led to stopping the anti-thyroid drugs, and was treated successfully with 131I ablation therapy. The relevance of the article is that Graves’ disease is uncommon in the paediatric age range (especially in children younger than 6 years old), and developing complications due to a possible late diagnosis. Agranulocytosis as a potentially serious adverse effect following the use of anti-thyroid drugs, and the few reported cases of ablation therapy with 131I at this age, makes this case unique (AU)


Assuntos
Humanos , Feminino , Pré-Escolar , Doença de Graves/complicações , Doença de Graves , Agranulocitose/complicações , Agranulocitose , Antitireóideos/efeitos adversos , Radioisótopos do Iodo/uso terapêutico , Doença de Graves/terapia , Cintilografia , Pertecnetato Tc 99m de Sódio/administração & dosagem , Pertecnetato Tc 99m de Sódio/análise , Glândula Tireoide/patologia , Glândula Tireoide , Comorbidade
4.
Rev Esp Med Nucl Imagen Mol ; 36(4): 260-262, 2017.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28392335

RESUMO

The case is presented of a 3 year-old girl with mitochondrial disease (subacute necrotizing encephalomyelopathy of Leigh syndrome), v-stage chronic kidney disease of a diffuse mesangial sclerosis, as well as developmental disorders, and diagnosed with hyperthyroidism Graves-Basedow disease. Six weeks after starting the treatment with neo-carbimazole, the patient reported a serious case of agranulocytosis. This led to stopping the anti-thyroid drugs, and was treated successfully with 131I ablation therapy. The relevance of the article is that Graves' disease is uncommon in the paediatric age range (especially in children younger than 6 years old), and developing complications due to a possible late diagnosis. Agranulocytosis as a potentially serious adverse effect following the use of anti-thyroid drugs, and the few reported cases of ablation therapy with 131I at this age, makes this case unique.


Assuntos
Agranulocitose/induzido quimicamente , Antitireóideos/efeitos adversos , Carbimazol/efeitos adversos , Doença de Graves/radioterapia , Radioisótopos do Iodo/uso terapêutico , Agranulocitose/terapia , Antitireóideos/uso terapêutico , Transfusão de Sangue , Carbimazol/uso terapêutico , Pré-Escolar , Deficiências do Desenvolvimento/complicações , Quimioterapia Combinada , Feminino , Doença de Graves/complicações , Doença de Graves/tratamento farmacológico , Humanos , Doença de Leigh/complicações , Síndrome Nefrótica/complicações , Propranolol/uso terapêutico , Esclerose/complicações
5.
Rehabilitación (Madr., Ed. impr.) ; 50(4): 267-270, oct.-dic. 2016. ilus
Artigo em Espanhol | IBECS | ID: ibc-158691

RESUMO

Se presenta el caso de una paciente de 41 años que se diagnostica de flebolinfedema primario con localización en miembro superior izquierdo asociado a síndrome de Klippel-Trénaunay, que no presentó manifestación clínica hasta los 37 años de edad, momento de aparición de la tríada clínica característica de angiomas cutáneos, varicosidades e hipertrofia de los tejidos blandos. La relevancia de este artículo radica en que se trata de una enfermedad rara y congénita, que se manifiesta en la infancia o adolescencia, con afectación más frecuente en miembros inferiores. Su etiopatogenia es aún desconocida, surgiendo casos esporádicos, aunque se cree que podría ser debido a una alteración en el desarrollo del mesodermo en el feto, que afecta a las líneas angioblásticas, linfoblásticas y osteoblásticas. Es importante conocer los diferentes signos clínicos para un diagnóstico y tratamiento precoz, el cual suele ser sintomático y la rehabilitación constituye un pilar fundamental dentro del tratamiento multidisciplinar (AU)


The case is presented of a 41 years old patient with primary lymphedema diagnostic in her left upper limb associated with Klippel-Trénaunay syndrome, who did not present any clinical manifestations until 37 years old, time of appearance of the characteristic clinical triad of cutaneous angiomatosis, varicose veins and hypertrophy. The relevance of this article is that it is a rare and congenital disease. This syndrome usually manifests in childhood or adolescence with more frequent involvement of the lower limbs. Its etiopathogeny is still unexplained, emerging sporadic cases, although it is believed it could be due to fetal's mesoderm development alteration, which affecting angioblastic, lymphoblastoid and osteoblastic lines. The importance of an early correct diagnosis and its symptomatic treatment, where rehabilitation has a fundamental role within the multidisciplinary approach is emphasized (AU)


Assuntos
Humanos , Feminino , Adulto , Linfedema/complicações , Linfedema/diagnóstico , Linfedema/reabilitação , Síndrome de Klippel-Feil/complicações , Diagnóstico Precoce , Hipertrofia/complicações , Massagem , Drenagem/métodos , Linfedema/fisiopatologia , Linfedema , Cintilografia/instrumentação , Cintilografia/métodos , Extremidade Superior/fisiopatologia , Extremidade Superior
10.
Rev. esp. med. nucl. imagen mol. (Ed. impr.) ; 32(4): 253-256, jul.-ago. 2013.
Artigo em Inglês | IBECS | ID: ibc-113491

RESUMO

En este caso la gammagrafía con 67Ga-citrato se presenta como una herramienta útil para valorar la reactivación y la extensión de la enfermedad. La reticulohistiocitosis multicéntrica es una enfermedad sistémica rara de etiología no conocida. Se caracteriza por provocar artropatía erosiva, así como lesiones cutáneas. Su diagnóstico y tratamiento deben realizarse precozmente para evitar secuelas. Se presenta el caso de un varón de 67 años con antecedentes de reticulohistiocitosis multicéntrica y artroplastia en la cadera izquierda que acude por dolor en el miembro inferior izquierdo, siendo diagnosticado de luxación de prótesis de cadera izquierda. Durante el ingreso se realiza una gammagrafía ósea con 99mTc-HDP y una gammagrafía con 67Ga-citrato donde se evidencia la ausencia de actividad inflamatoria ósea en la pelvis que contraindique la cirugía. Además, se observa una captación bilateral en las partes blandas de las grandes articulaciones compatible con la persistencia de la actividad inflamatoria secundaria a reticulohistiocitosis multicéntrica(AU)


Multicentric reticulohistiocytosis is a rare systemic disease of unknown etiology. It is characterized by erosive arthritis and skin lesions. Diagnosis and treatment should be performed early to avoid sequelaes. We report the case of a 67-year-old man diagnosed with multicentric reticulohistiocytosis and left hip arthorplasty. The patient consulted for local pain in his left leg. Final diagnosis was left prosthetic dislocation. During admission, a bone scintigraphy with 99mTc-HDP and scintigraphy with 67Ga-citrate was performed, showing no evidence of inflammatory activity in pelvis that contraindicating surgery. Besides it showed bilateral uptake in soft tissue of large joints compatible with persistent inflammatory activity secondary to multicentric reticulohistiocytosis. In this case scintigraphy with 67Ga-citrate, is a useful tool to assess the recovery and extent of disease(AU)


Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , /instrumentação , /métodos , Histiocitose de Células não Langerhans , Gálio , Isótopos de Gálio , Tecnécio , Ciclofosfamida/uso terapêutico , Doxorrubicina/uso terapêutico , Vincristina/uso terapêutico , Prednisona/uso terapêutico , Imageamento por Ressonância Magnética , /métodos
11.
Rev Esp Med Nucl Imagen Mol ; 32(4): 253-6, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-23219024

RESUMO

Multicentric reticulohistiocytosis is a rare systemic disease of unknown etiology. It is characterized by erosive arthritis and skin lesions. Diagnosis and treatment should be performed early to avoid sequelaes. We report the case of a 67-year-old man diagnosed with multicentric reticulohistiocytosis and left hip arthorplasty. The patient consulted for local pain in his left leg. Final diagnosis was left prosthetic dislocation. During admission, a bone scintigraphy with (99m)Tc-HDP and scintigraphy with (67)Ga-citrate was performed, showing no evidence of inflammatory activity in pelvis that contraindicating surgery. Besides it showed bilateral uptake in soft tissue of large joints compatible with persistent inflammatory activity secondary to multicentric reticulohistiocytosis. In this case scintigraphy with (67)Ga-citrate, is a useful tool to assess the recovery and extent of disease.


Assuntos
Citratos , Gálio , Histiocitose de Células não Langerhans/diagnóstico por imagem , Compostos Radiofarmacêuticos , Idoso , Humanos , Masculino , Cintilografia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...